In addition, the small molecule PT2399 directly inhibits HIF2A and causes tumor regression in a targeted manner in preclinical models of primary and metastatic pVHL-deficient renal cell carcinoma [173]. The gene discussed is EPAS1; the disease is hereditary clear cell renal cell carcinoma.